IMIGLUCERASE
IMIGLUCERASE is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Cerezyme. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- IMIGLUCERASE
- Brand Names
- Cerezyme
- Application Number
- BLA020367
- Sponsor
- Sanofi S.r.l.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- IMIGLUCERASE
Indications and Usage
1 INDICATIONS AND USAGE CEREZYME is indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adults and pediatric patients. CEREZYME is a hydrolytic lysosomal glucocerebrosidase-specific enzyme indicated for the treatment of non-central nervous system (CNS) manifestations of Type 1 or Type 3 Gaucher disease in adults and pediatric patients. ( 1 )